These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32733676)

  • 1. Building an innovation system of medical devices in China: Drivers, barriers, and strategies for sustainability.
    Cheong ST; Li J; Ung COL; Tang D; Hu H
    SAGE Open Med; 2020; 8():2050312120938218. PubMed ID: 32733676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China.
    Zhang MY; Li J; Hu H; Wang YT
    Health Res Policy Syst; 2015 Nov; 13():64. PubMed ID: 26537659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
    Hu H; Chung CC
    Int J Health Policy Manag; 2015 Sep; 4(12):823-9. PubMed ID: 26673466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. China's Particle Therapy Equipment Market: Opportunities Outweigh Challenges.
    Dai Z; Ma Y; Li Q
    Front Public Health; 2020; 8():602776. PubMed ID: 33335881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy experimentation and innovation as a response to complexity in China's management of health reforms.
    Husain L
    Global Health; 2017 Aug; 13(1):54. PubMed ID: 28774319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese villages and their sustainable future: the European Union-China-Research Project "SUCCESS".
    Dumreicher H
    J Environ Manage; 2008 Apr; 87(2):204-15. PubMed ID: 17888563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of technology-environmental innovation on CO
    Chen F; Zhao T; Liao Z
    Environ Sci Pollut Res Int; 2020 Aug; 27(23):29485-29501. PubMed ID: 32445144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental Policy Integration in the Energy Sector of China: The Roles of the Institutional Context.
    Ruan X; Sheng R; Lin T
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33333863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clean energy storage technology in the making: An innovation systems perspective on flywheel energy storage.
    Wicki S; Hansen EG
    J Clean Prod; 2017 Sep; 162():1118-1134. PubMed ID: 29263586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems and processes for regulation of investigational medical devices in Uganda.
    Mpaata CN; Matovu B; Takuwa M; Kiwanuka N; Lewis S; Norrie J; Ononge S; Tuck S; Wolters M; Demulliez M; Ssekitoleko RT
    Front Med Technol; 2022; 4():1054120. PubMed ID: 36756148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review and approval of medical devices in China: Changes and reform.
    Liu W; Shi X; Lu Z; Wang L; Zhang K; Zhang X
    J Biomed Mater Res B Appl Biomater; 2018 Aug; 106(6):2093-2100. PubMed ID: 29080388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution Decision, Drivers and Green Innovation Performance for Collaborative Innovation Center of Ecological Building Materials and Environmental Protection Equipment in Jiangsu Province of China.
    Fang W; Tang L; Cheng P; Ahmad N
    Int J Environ Res Public Health; 2018 Oct; 15(11):. PubMed ID: 30366457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Industrial Policy Could Accelerate Innovation In The Life Sciences.
    Robinson JC
    Health Aff (Millwood); 2023 Aug; 42(8):1045-1053. PubMed ID: 37549321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A].
    Sun Q; Yan L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jan; 30(1):43-52. PubMed ID: 16646425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development and reform of public health in China from 1949 to 2019.
    Wang L; Wang Z; Ma Q; Fang G; Yang J
    Global Health; 2019 Jul; 15(1):45. PubMed ID: 31266514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and learning in complex, rapidly changing health systems: China's management of health sector reform.
    Xiao Y; Husain L; Bloom G
    Global Health; 2018 Nov; 14(1):112. PubMed ID: 30454037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to Creating Scalable Business Models for Digital Health Innovation in Public Systems: Qualitative Case Study.
    Kelley LT; Fujioka J; Liang K; Cooper M; Jamieson T; Desveaux L
    JMIR Public Health Surveill; 2020 Dec; 6(4):e20579. PubMed ID: 33300882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.